子宫内膜异位症相关不孕:严重疼痛症状不影响辅助生殖技术结局
该观察性队列研究纳入354例子宫内膜异位症患者,在2014年10月至2021年10月期间接受辅助生殖技术(ART)治疗,共711个周期。主要结局为每例患者的累积活产率(CLBR)。结果显示,严重疼痛症状与ART活产率降低无关,仅年龄>35岁和抗苗勒管激素<1.2 ng/ml与活产负相关。
要点
- 严重疼痛症状(VAS≥7)与ART累积活产率无显著关联(P=0.229)。
- 年龄>35岁和抗苗勒管激素<1.2 ng/ml是ART活产失败的显著因素(P<0.001)。
- 子宫内膜异位症诊断基于影像学标准,而非手术。
核心结论
- 严重疼痛症状与子宫内膜异位症患者的ART活产率降低无关。
研究设计与样本
- 观察性队列研究,纳入354例子宫内膜异位症患者,在三级大学医院于2014年10月至2021年10月期间接受ART,共711个周期。
主要发现
- 每例患者累积活产率(CLBR)为63.8%(226/354)。
- 活产组与非活产组之间,各疼痛症状的平均VAS评分及严重疼痛患者比例均无显著差异(P=0.229)。
- 与ART活产负相关的显著因素为年龄>35岁(P<0.001)和抗苗勒管激素水平<1.2 ng/ml(P<0.001)。
关键数值与推荐
- 严重疼痛定义为至少一种症状的VAS评分≥7分。
- 子宫内膜异位症表型分布:浅表型3.1%,卵巢子宫内膜异位囊肿8.2%,深部浸润型88.7%。
临床怎么用
- 作者认为,对于不孕的子宫内膜异位症患者,选择ART或手术的决策应基于多方面因素,包括患者选择、相关不孕因素、子宫内膜异位症表型以及药物治疗对疼痛症状的有效性,通过多学科专家团队指导的个体化方法进行。
局限性
- 子宫内膜异位症的诊断基于影像学而非手术。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do severe endometriosis-related painful symptoms impact ART live birth rates? SUMMARY ANSWER: Severe pain symptoms are not associated with reduced ART live birth rates in endometriosis patients. WHAT IS KNOWN ALREADY: ART is currently recognized as one of the main therapeutic options to manage endometriosis-related infertility. Presently, no data exist in the literature regarding the association between the core symptom of the disease, e.g. pain and ART reproductive outcomes. STUDY DESIGN, SIZE, DURATION: Observational cohort study of 354 endometriosis patients, who underwent ART at a tertiary care university hospital, between October 2014 and October 2021. Diagnosis of endometriosis was based on published imaging criteria using transvaginal sonography and magnetic resonance imaging, and histologically confirmed in women who had a previous history of endometriosis surgery (n = 127, 35.9%). PARTICIPANTS/MATERIALS, SETTING, METHODS: The intensity of painful symptoms related to dysmenorrhea (DM), dyspareunia (DP), noncyclic chronic pelvic pain, gastrointestinal (GI) pain, or lower urinary tract pain was evaluated using a 10-point visual analog scale (VAS), before ART. Severe pain was defined as having a VAS of 7 or higher for at least one symptom. The main outcome measure was the cumulative live birth rate (CLBR) per patient. We analyzed the impact of endometriosis-related painful symptoms on ART live births using univariable and multivariate analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Three hundred and fifty-four endometriosis patients underwent 711 ART cycles. The mean age of the population was 33.8 ± 3.7 years, and the mean duration of infertility was 3.6 ± 2.1 years. The distribution of the endometriosis phenotypes was 3.1% superficial endometriosis, 8.2% ovarian endometrioma, and 88.7% deep infiltrating endometriosis. The mean VAS scores for DM, DP, and GI pain symptoms were 6.6 ± 2.7, 3.4 ± 3.1, and 3.1 ± 3.6, respectively. Two hundred and forty-two patients (68.4%) had severe pain symptoms. The CLBR per patient was 63.8% (226/354). Neither the mean VAS scores for the various painful symptoms nor the proportion of patients displaying severe pain differed significantly between patients who had a live birth and those who had not, based on univariate and multivariate analyses (P = 0.229). The only significant factors associated with negative ART live births were age >35 years (P < 0.001) and anti-Müllerian hormone levels <1.2 ng/ml (P < 0.001). LIMITATIONS, REASONS FOR CAUTION: The diagnosis of endometriosis was based on imaging rather than surgery. This limitation is, however, inherent to the design of most studies on endometriosis patients reverting to ART first. WIDER IMPLICATIONS OF THE FINDINGS: Rather than considering a single argument such as pain, the decision-making process for choosing between ART and surgery in infertile endometriosis patients should be based on a multitude of aspects, including the patient's choice, the associated infertility factors, the endometriosis phenotypes, and the efficiency of medical therapies in regard to pain symptoms, through an individualized approach guided by a multidisciplinary team of experts. STUDY FUNDING/COMPETING INTEREST(S): No funding; no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Maignien C, Bourdon M, Parpex G, et al. Endometriosis-related infertility: severe pain symptoms do not impact assisted reproductive technology outcomes. Hum Reprod. 2024. PMID: 38142239. doi:10.1093/humrep/dead252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。